
Develop models to predict outcomes after intradetrusor injection of 100 or 200 units of onabotulinumtoxinA in women with non‐neurogenic urgency urinary incontinence (UUI).Models were developed using 307 women from two randomized trials assessing efficacy of onabotulinumtoxinA for non‐neurogenic UUI. Cox, linear and logistic regression models were fit using: (1) time to recurrence over 12 months, (2) change from baseline daily UUI episodes (UUIE) at 6 months, and (3) need for self‐catheterization over 6 months. Model discrimination of Cox and logistic regression models was calculated using c‐index. Mean absolute error determined accuracy of the linear model. Calibration was demonstrated using calibration curves. All models were internally validated using bootstrapping. Median time to recurrence was 6 (interquartile range [IQR]: 2–12) months...
Like
Save
Share